• Quotes
  • Shortcuts
The Executive's Internet
Tues, Apr 13th
icon
GoogleAmazonWikipedia


spacerspacer

 

 BUSINESS/FINANCE NEWS
Setup News Ticker
   BUSINESS/FINANCE NEWS
Searching for 'Vaccine Covid'. (Return)

MarketWatch MarketPulseApr 13, 2021
Moderna says that it COVID-19 vaccine continues to show 'strong efficacy'
Moderna Inc. said late Tuesday that its COVID-19 vaccine continued to show "strong efficacy," including greater than 90% efficacy against cases of COVID-19 and greater than 95% against severe cases of COVID-19 in a median six-month follow-up. New preclinical data also showed variant-specific booster vaccine candidates working, the company said. "We are looking forward to having the clinical data from our variant-specific booster candidates" as well as clinical data from a study of the vaccine in teens, Chief Executive Stéphane Bancel said in a statement. "The new preclinical data on our variant-specific vaccine candidates give us confidence that we can proactively address emerging variants." Moderna said it has delivered about 132 million doses of its vaccine globally. Also Tuesday, Pfizer Inc. Chief Executive Albert Bourla tweeted that his company was "ramping up" vaccine production and would be able to deliver more doses to the U.S., and ahead of time. U.S. regulators earlier Tuesday called for a temporary halt in using the Johnson & Johnson COVID-19 vaccine after six people out of the nearly 7 million who received the J&J shot were diagnosed with severe blood clots.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.



RELATED ARTICLES
Pfizer ramps up COVID-19 vaccine production for the U.S., CEO says (MarketWatch MarketPulse)

MarketWatchApr 13, 2021
Market Extra: J&J debt trades lower after pause of one-shot COVID-19 vaccine
Johnson & Johnson's corporate bonds are trading lower across the board Tuesday, after two leading U.S. health agencies recommended a pause on its one-shot COVID-19 vaccine after six vaccinated women developed blood clotting.

MarketWatch MarketPulseApr 13, 2021
S&P 500 books record high and Nasdaq rallies 1.1% as stock market reacts to Johnson & Johnson pause, hot CPI report
The S&P 500 finished at a record and technology shares closed in the green Tuesday as long-term government bond yields retreated despite data showing a surge in consumer prices in March. Investors were hit with early negative headlines after the Food and Drug Administration and the Centers for Disease Control and Prevention requested the immediate halt in the use of Johnson & Johnson's one-shot COVID vaccine out of "an abundance of caution" due to extremely rare blood-clotting issues in women. That report was followed by a highly anticipated reading of March that showed U.S. consumer prices rising on the month for the fourth month in a row, with the pace of inflation hitting the highest level in 21/2 years. The rate of inflation over the past year shot up to 2.6% from 1.7% in the prior month, marking the highest level since the fall of 2018. The S&P 500 closed at a record at around 4,141, about 0.3% higher, while the Nasdaq Composite Index closed up 1.1% as technology shares scored a bounce off reteating bond yields. The 10-year Treasury note yielded 1.62% , with the decline following the CPI report, which some traders said wasn't as hot as expected, helping support some bids for long-dated bonds and relieving some of the pressure of higher borrowing costs on investments viewed as speculative like tech and tech-related shares. The Dow Jones Industrial Average , however, closed off 0.2% at aroound 33,677.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.



RELATED ARTICLES
Why Emergent BioSolutions Stock Fell Today (The Motley Fool)

CNBC BusinessApr 13, 2021
Dr. Anthony Fauci explains what the U.S. pause on J&J's Covid vaccine means
Dr. Fauci said the pause will give U.S. health regulators the time they need to thoroughly investigate how six women developed a rare blood clotting disorder.

USA Today MoneyApr 13, 2021
COVID-19 vaccine freebies such as gift cards, Krispy Kreme donuts: Are they a good or bad way to encourage shots?
First, Krispy Kreme offered free donuts for people who get COVID-19 vaccinations. Next up could be local governments handing out gift cards. Is that OK?      

CNBC BusinessApr 13, 2021
Panicked patients call doctors as Covid vaccine hesitancy rises with J&J blood clot issue
The warning from U.S. officials to states is likely to fuel more hesitancy in taking J&J's shot and other vaccines, threatening to stall the pandemic recovery.

RELATED ARTICLES
Risk of blood clots is higher from Covid than from J&J shot, says doctor who worked on other vaccine trials (CNBC Business)

MarketWatchApr 13, 2021
Coronavirus Update: U.S. COVID vaccine program faces setback with J&J jab, as experts say there is no cause for alarm
The U.S. COVID-19 vaccine program was facing a setback Tuesday, when the nation's two leading health agencies recommended a pause in the use of the Johnson & Johnson vaccine to allow their scientists investigate six cases of blood clotting in individuals who had been vaccinated.

USA Today MoneyApr 13, 2021
COVID vaccine freebies like gift cards, Krispy Kreme donuts: Are they a good or bad way to encourage shots?
First, Krispy Kreme offered free donuts for people who get COVID vaccinations. Next up could be local governments handing out gift cards. Is that OK?      

Chicago Tribune Business NewsApr 13, 2021
Chicago employers could face up to $5,000 fine for not letting workers take time off to get COVID-19 vaccines
Chicago businesses would face fines up to $5,000 for not allowing workers to take time off to get COVID-19 vaccines under a proposal by Mayor Lori Lightfoot that moved closer to passage on Tuesday.

MarketWatchApr 13, 2021
: Airline stocks stumble after vaccine rollout snag
U.S. airline stocks fall after Johnson & Johnson's COVID-19 vaccine is halted with investors keeping an eye on upcoming airline earnings and the uptick in air-travel demand ahead of summer.

MarketWatch MarketPulseApr 13, 2021
Biden says U.S. has enough vaccines for 'every single' American
President Joe Biden said Tuesday the U.S. has enough vaccine "for every single solitary American," in the wake of U.S. health authorities' recommendation of a pause in use of the Johnson & Johnson COVID-19 vaccine. Regulators have suggested temporarily halting use of J&J's vaccine while they examine six severe cases of rare blood clots that have been reported in people who have received the shot. Biden echoed comments made earlier by Jeff Zients, the White House's COVID-19 response coordinator, saying the administration has secured enough doses of the Pfizer and Moderna vaccines. There have been six clotting cases out of the roughly 6.8 million people in the U.S. who have received the J&J vaccine.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.



Google Business NewsApr 13, 2021
Michigan Republicans fire back after CDC director tells state to shut down: 'not the answer' - Fox News
Michigan Republicans fire back after CDC director tells state to shut down: 'not the answer'  Fox NewsMichigan vaccine rebuff puts Biden and a top ally in a dicey political spot  CNN Michigan will pause use of Johnson & Johnson's COVID-19 vaccine, following CDC guidance  MLive.comU.S. making strides in COVID vaccination efforts as Michigan grapples with a surge in cases  CBS News

Chicago Tribune Business NewsApr 13, 2021
‘Pause' for Johnson & Johnson COVID-19 vaccine over reports of blood clots could jeopardize rollout of vaccines worldwide
The U.S. is recommending a "pause" in administration of the single-dose Johnson & Johnson COVID-19 vaccine to investigate reports of potentially dangerous blood clots.

FT.com - China, Economy & TradeApr 12, 2021
Coronavirus: US has given Covid-19 vaccines to 120m Americans as rollout picks up - as it happened
Green energy supplier takes top spot and London remains the city with the most high-growth businesses
TRENDING TAGS
VaccineJohnson J&J Covid & pause
Covid-19vaccine Johnson reports & Coronavirus
stockToday Buy Johnson market vaccine
Johnson& vaccine blood pause COVID-19
J&J
Bideninfrastructure plan Washington summit Putin
COVIDCOVID-19 vaccine Johnson J&J &
inflationprices March Gold surge Consumer
&Johnson vaccine J&J pause Covid
ChinaTech steel debt record demand

NEWS SOURCES
Top News (Business News)
Accounting Today
AdWeek News
Banking Business Review
Barron's This Week Magazine
Barron's Up and Down Wall Street Daily
Brad Ideas
Chicago Tribune Business News
CNBC Business
CNBC Economy
CNBC Finance
CNN/Money
CNN/Money Real Estate News
Dismal.com: Analysis
Dismal.com: Indicators
Enterprise Application News
Entrepreneur.com
Forbes Headlines
Forbes Social Media News
FT.com - China, Economy & Trade
FT.com - Financial Markets
FT.com - Hedge Funds
FT.com - Telecoms
FT.com - US
Google Business News
Google Market News
HBS Working Knowledge
Inc.com
INSEAD Knowledge
International Tax Review
Kiplinger
Knowledge@Wharton
L.S. Starrett News
MarketWatch
MarketWatch Breaking News
MarketWatch MarketPulse
McKinsey Quarterly
MSNBC.com: Business
Nielsen Trends
NonProfit Times
NPR Topics: Business
NYTimes Business
OpinionJournal.com
Private Equity Breaking News
Reuters Business
Reuters Company News
Reuters Money
SEC.gov Updates: News Digest
SHRM HR News
Tax Policy News
The Economist International News
The Motley Fool
USA Today Money
Wall Street Journal US Business
Wall Street Transcript
Washington Post Business
WSJ Asia
WSJ Europe
WSJ MoneyBeat
WSJ Opinion
WSJ US News
WSJ World Markets
Yahoo Business
  • CEOExpress
  • 1 Boston Place | Suite 2600
    Boston MA 02108
  • Contact
  • As an Amazon Associate
    CEOExpress earns from
    qualifying purchases.

©1999-2021 CEOExpress Company LLC